BU and Red Hat Extend, Expand Partnership for Cloud Research bu.edu - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bu.edu Daily Mail and Mail on Sunday newspapers.
VGXI and Geneos Therapeutics Expand Partnership for Personalized Cancer Immunotherapies
Share Article
Texas-based GMP Plasmid CDMO VGXI, Inc. and Geneos Therapeutics, Inc. Expand their Clinical Manufacturing Supply Agreement in Support of Geneos’ Ongoing GT-30 Phase Ib/IIa Clinical Trial for advanced hepatocellular carcinoma (HCC).
The renewed agreement is a testament to the experience and capabilities of the VGXI team in meeting the challenging requirements of this project. THE WOODLANDS, Texas (PRWEB) March 16, 2021 VGXI, Inc., an industry leading manufacturer for pre-clinical through cGMP clinical plasmid DNA, announced that its partner Geneos Therapeutics, Inc. has executed a new purchasing contract under their current Clinical Manufacturing Supply Agreement to support the expansion of the ongoing GT-30 clinical trial. The Geneos trial is focused on treatment of patients with advanced hepatocellular carcin